Search Results for author: GuoWei Wei

Found 4 papers, 2 papers with code

PLPCA: Persistent Laplacian Enhanced-PCA for Microarray Data Analysis

1 code implementation9 Jun 2023 Sean Cottrell, Rui Wang, GuoWei Wei

Over the years, Principal Component Analysis (PCA) has served as the baseline approach for dimensionality reduction in gene expression data analysis.

Dimensionality Reduction

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

1 code implementation2 Nov 2022 Hongsong Feng, GuoWei Wei

We are particularly interested in the hERG-cardiotoxicity of compounds collected in the DrugBank database considering that many DrugBank compounds have been approved for therapeutic treatments or have high potential to become drugs.

Drug Discovery

Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies

no code implementations13 Oct 2020 Jiahui Chen, Kaifu Gao, Rui Wang, GuoWei Wei

This discovery implies the vulnerability of current vaccines and antibody drugs to new mutations.

Representability of algebraic topology for biomolecules in machine learning based scoring and virtual screening

no code implementations27 Aug 2017 Zixuan Cang, Lin Mu, GuoWei Wei

This work introduces a number of algebraic topology approaches, such as multicomponent persistent homology, multi-level persistent homology and electrostatic persistence for the representation, characterization, and description of small molecules and biomolecular complexes.

BIG-bench Machine Learning Descriptive

Cannot find the paper you are looking for? You can Submit a new open access paper.